Clinical pharmacist prescribing activities in the Veterans Health Administration

Ourth, Heather; Groppi, Julie; Morreale, Anthony P.; Quicci-Roberts, Kimberly

doi:10.2146/ajhp150778

Cited by 45 publications

(40 citation statements)

References 2 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…One possible explanation is that patient groups that did not yield significant associations may have inherent characteristics that were not considered in these models. Additionally, pharmacists were excluded as providers even though 41 percent of pharmacists have prescribing privileges . Not all pharmacists are considered providers at the VA, and their duties were not easily determined from the current data.…”

Section: Discussionmentioning

confidence: 99%

“…In 2017, the VA was comprised of 130 stations, which encompassed 179 Veterans Affairs Medical Centers (VAMCs) and 1061 Community‐Based Outpatient Clinics (CBOCs) that performed approximately 109 million outpatient visits, treated 615 000 inpatients (medical and surgical), and treated 149 000 mental health inpatients . The VA has a total workforce of approximately 25 000 physicians, 95 000 nurses, and nearly 8000 pharmacists with an annual operating budget of approximately $72 billion …”

Section: Design and Methodsmentioning

confidence: 99%

“…19 The VA has a total workforce of approximately 25 000 physicians, 95 000 nurses, and nearly 8000 pharmacists with an annual operating budget of approximately $72 billion. 19,20 This analysis was performed at the station level; all stations (N = 130) across the VA were included. Each station consists of one or more VAMCs with its surrounding satellites or CBOCs.…”

Section: Samplementioning

confidence: 99%

See 2 more Smart Citations

Implementation evaluation of academic detailing on naloxone prescribing trends at the United States Veterans Health Administration

Bounthavong

Devine

Christopher

et al. 2019

Health Services Research

View full text Add to dashboard Cite

Objective Academic detailing in partnership with the Opioid Overdose Education and Naloxone Distribution (OEND) program was implemented to increase naloxone access for the prevention of opioid overdose mortality in veterans at the U.S. Department of Veterans Affairs (VA). However, implementation was not uniform leading to varying levels of intervention exposure potentially impacting naloxone prescribing. We examined the impact of implementation strength (proportion of providers exposed to academic detailing) at each station on naloxone prescribing from September 2014 to December 2017. Study Design and Setting Retrospective cohort design with fixed effects models at the VA. Data Collection/Extraction Methods We used VA Corporate Data Warehouse for data on pharmacy dispensing, station‐, provider‐ and patient‐level characteristics. OEND‐specific academic detailing activities came from data recorded by academic detailers using Salesforce.com. Principal Findings VA stations wherein 100 percent of providers exposed to an OEND‐related academic detailing educational outreach visit experienced an increased incident rate of naloxone prescribing that was 5.52 times the incident rate of stations where no providers were exposed; alternatively, this is equivalent to an average monthly increase of 2.60 naloxone prescriptions per 1000 population at risk for opioid overdose. Conclusions Our findings highlight the importance of academic detailing's implementation strength on naloxone prescribing. Decision makers must carefully consider the implementation process to achieve the greatest effectiveness from the intervention.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Design and Methodsmentioning

confidence: 99%

Section: Samplementioning

confidence: 99%

See 1 more Smart Citation

Implementation evaluation of academic detailing on naloxone prescribing trends at the United States Veterans Health Administration

Bounthavong

Devine

Christopher

et al. 2019

Health Services Research

View full text Add to dashboard Cite

show abstract

“…The clinical pharmacist is trained in clinical pharmacy practice and comprehensive medication management to include—but not limited to—clinical pharmacokinetics, therapeutics and clinical pharmacology 7. Several physician and medical organisations in the USA have acknowledged the benefits of physicians and pharmacists working collaboratively to improve patients’ quality of life and reduce medication-related adverse effects 8–12.…”

Section: Introductionmentioning

confidence: 99%

“…About 48 states in the USA have authorised some form of pharmacist prescribing 7. However, there remain barriers to the full integration of pharmacists with prescribing authority into healthcare delivery models, including issues of policy and legislation, compensation for services and access to health information technology systems 35.…”

Section: Introductionmentioning

confidence: 99%

Differences and similarities in clinical pharmacy practice in China and the United States: a narrative review

2017

Eur J Hosp Pharm

View full text Add to dashboard Cite

The clinical pharmacy practice provided by pharmacists aims to improve the rational use of medication and enhance the quality of life of patients. Although clinical pharmacy in the USA has been developing for almost 60 years, it began in China only in 2005. Despite this, rapid development in clinical pharmacy has been achieved under the support of China’s Ministry of Health. This article aims to compare the differences between, and similarities of, clinical pharmacy practice in China and the USA.

show abstract

Expanding the pharmacist's scope of practice at the state level: Support for board certification within the credentialing process

Lee¹,

Saseen

Beckman

et al. 2019

J Am Coll Clin Pharm

View full text Add to dashboard Cite

The practice of pharmacy continues to evolve as more pharmacists complete the education, training, and credentialing necessary to provide direct patient care. Ongoing advocacy of legal and regulatory changes at the state level is essential to support an expanded scope of practice for these qualified pharmacists. Determining the eligibility requirements for pharmacists in advanced practice roles is an important component of this advocacy. Board certification through the Board of Pharmacy Specialties (BPS)is an appropriate qualifying credential. This commentary will overview board certification through BPS, differentiate board certification from a certificate program, and provide examples of state pharmacy practice act language that includes board certification as a qualifying credential. The commentary will include a recommendation and rationale for board certification to be included in state pharmacy practice acts as the credential required for pharmacists to practice in direct patient care roles. This commentary will serve as a resource for advocates working at the state level to revise pharmacy practice acts.

show abstract

Clinical pharmacist prescribing activities in the Veterans Health Administration

Cited by 45 publications

References 2 publications

Implementation evaluation of academic detailing on naloxone prescribing trends at the United States Veterans Health Administration

Implementation evaluation of academic detailing on naloxone prescribing trends at the United States Veterans Health Administration

Differences and similarities in clinical pharmacy practice in China and the United States: a narrative review

Expanding the pharmacist's scope of practice at the state level: Support for board certification within the credentialing process

Contact Info

Product

Resources

About